IU Simon Cancer Center

Indianapolis, Indiana 46202

1 studies enrolling now · 21 studies all time

What they study most

Acinar Cell Adenocarcinoma of the Pancreas, Acute Lymphoblastic Leukemia, Advanced Colorectal Cancer, Advanced Solid Tumor, Advanced, Metastatic Breast Cancer, Bladder Cancer, Brain Cancer, Brain Tumor, Breast Cancer, Breast Cancer Female, Breast Neoplasms, Cervical Cancer

Studies at this site

• A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors — Recruiting now
• A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib — Running, not enrolling
• A Study of Evorpacept (ALX148) With Azacitidine for Higher Risk Myelodysplastic Syndrome (ASPEN-02) — Stopped early
• Genotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal Cancer — Completed
• Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer — Completed
• A Safety, Tolerability and Pharmacokinetic Study of TAS-114 in Combination With Capecitabine in Patients With Advanced Solid Tumors — Completed
• Effect of Curcumin on Dose Limiting Toxicity and Pharmacokinetics of Irinotecan in Patients With Solid Tumors — Completed
• M3541 in Combination With Radiotherapy in Solid Tumors — Stopped early
• A Study of Abemaciclib in Participants With Cancer That is Advanced or Has Spread to Another Part(s) of the Body — Completed
• Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer — Status unconfirmed
• Effects of Aromatase Inhibitor Therapy on Muscle Function — Completed
• An Initial Safety Study of Gedatolisib Plus PTK7-ADC for Metastatic Triple-negative Breast Cancer — Completed
• Acceleration of Platelet Recovery Following Autologous Peripheral Blood Stem Cell Transplant (PBSC) in Hodgkin, Non-Hodgkin Lymphoma or Multiple Myeloma Patients — Stopped early
• Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib — Completed
• A Study of LY3381916 Alone or in Combination With LY3300054 in Participants With Solid Tumors — Stopped early
• A Study of Olaratumab and Doxorubicin in Participants With Advanced Soft Tissue Sarcoma — Completed
• Lenalidomide and High Dose Melphalan Followed by Autologous Stem Cell Transplant in Multiple Myeloma — Completed
• Ultrasound-Guided Photodynamic Therapy With Photofrin & Gemcitabine for Patients With Locally Advanced Pancreatic Cancer — Completed
• Establishing of Neuronal-like Cells From Patients With Cisplatin-Induced Peripheral Neuropathy — Withdrawn before enrolling
• IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma — Completed
• Sitagliptin Umbilical Cord Blood Transplant Study — Completed